Clinical Trial Update: Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X [Phase 1]

View source ↗

Summary

This Clinical Trial Update reports the completion of a Phase I study evaluating the ocular and systemic safety and tolerability of OC-10X for proliferative diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• OC-10X

Snippet

Sponsor: OcuCure Therapeutics, Inc. | Conditions: Proliferative Diabetic Retinopathy (PDR) | Phase 1 | Status: COMPLETED